Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Catherine J. Hwang, MD
Healthcare Professional Ophthalmologist
Cleveland Clinic Main Campus
Mail Code i32
9500 Euclid Avenue
Cleveland, Ohio, United States
Dr. Catherine J. Hwang was born in New York and raised in Atlanta, Georgia. She graduated from Emory University with a Bachelor of Science degree in Biology and minor in Sociology and then traveled to Philadelphia where she obtained her MD degree at the University of Pennsylvania. She stayed at the University of Pennsylvania, Scheie Eye Institute, for her ophthalmology residency. She then moved to Los Angeles and completed an advanced oculofacial and orbital surgery fellowship at the Jules Stein Eye Institute, UCLA Medical Center (a fellowship certified by both the American Society of Ophthalmic Plastics and Reconstructive Surgery and the American Academy of Cosmetic Surgery).
After this two year fellowship, Dr. Hwang completed an additional year of fellowship in cosmetic facial surgery and rhinoplasty in Santa Monica, California. She also travelled internationally studying in Europe and Asia on botulinum toxin, fillers, and Asian eyelid surgery.
Dr. Hwang travels extensively lecturing nationally and internationally. She has served as Assistant Clinical Professor, University of California, Los Angeles, Division of Oculofacial and Orbital Surgery (2010-2016). Her clinical interest lies in treating blepharoplasty, ectropion, eyelid ptosis, thyroid eye disease, orbit tumors, etc.
Representative Publications:
Dimensions and Morphologic Variability of the Retro-Orbicularis Oculi and Frontalis Muscle Fat Pad
Cautery Selection for Oculofacial Plastic Surgery in Patients with Implantable Electronic Devices
Age-Related Changes in Globe Position
Paracanthal “One-Snip” Decompression in a Cadaver Model of Retrobulbar Hemorrhage
Related Content
-
Diagnosed With Graves’ Disease Then Thyroid Cancer – LorrieA patient’s thyroid cancer story about...
-
Glucocorticoid Regimens for Prevention of Graves’ Ophthalmopathy Progression Following Radioiodine Treatment: ...Background: Glucocorticoid (GC) therapy...
-
Casey Eye Institute – Thyroid Eye Disease CenterAs part of Oregon Health & Science U...
-
Randomized Controlled Trial of Rituximab in Patients With Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
Timothy James McCulley, MDTimothy McCulley, MD, is professor and c...
-
Michael K. Yoon, MDDr. Michael Yoon is a member of the Mass...
-
Smoking Induces Overexpression of Immediate Early Genes in Active Graves’ OphthalmopathyBackground: Cigarette smoking is a risk...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.